NASDAQ Endocrinology Market News

PhaseBio Pharmaceuticals Announces Positive Data for Type 2 Diabetes Treatments PE0139 and PB1023

PE0139 was well tolerated; pharmacokinetic / pharmacodynamic profile supports once-weekly dosing PE0139 demonstrated synergistic ...

AMAG Pharmaceuticals Announces New Senior Management Appointments

WALTHAM, Mass., June 2, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced ...

Type 2 Diabetes Trial Results Published In Diabetes Care

NEW YORK and MELBOURNE, Australia, July 22, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; ...

Mannkind Announces Addition of Chief Medical Officer

VALENCIA, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced the ...